Participants 88 162 4
patients with non-small cell lung cancer not suitable for curative therapy
Participants 743 895 10
Patients were eligible if they had stage I-IIIB NSCLC, unsuitable for curative therapy, or stage IV with a PET-detected extracranial solitary metastasis
Participants 1290 1326 6
Eighty-four patients were randomized
